Your browser doesn't support javascript.
loading
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
Sanders, D B; Hart, I K; Mantegazza, R; Shukla, S S; Siddiqi, Z A; De Baets, M H V; Melms, A; Nicolle, M W; Solomons, N; Richman, D P.
Affiliation
  • Sanders DB; Division of Neurology, Duke University Medical Center, Durham, NC, USA. Donald.Sanders@Duke.edu
Neurology ; 71(6): 400-6, 2008 Aug 05.
Article in En | MEDLINE | ID: mdl-18434638
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunosuppressive Agents / Myasthenia Gravis / Mycophenolic Acid Type of study: Clinical_trials / Guideline / Observational_studies / Qualitative_research Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunosuppressive Agents / Myasthenia Gravis / Mycophenolic Acid Type of study: Clinical_trials / Guideline / Observational_studies / Qualitative_research Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos